Introduction: Secretoneurin (SN) is a novel biomarker that provides prognostic information in patients with cardiovascular disease. In experimental models, SN production is increased in the failing myocardium. Currently, no information is available on SN production in human myocardium. Accordingly, we wanted to determine the trans-cardiac gradient of SN in patients with Takotsubo syndrome (TTS), and to correlate circulating SN concentrations with indices of cardiac structure and function. Methods: We included 15 women diagnosed with TTS according to established criteria. Plasma SN concentrations were measured in blood samples obtained simultaneously from the aortic root and the coronary sinus. Coronary physiology was assessed by invasive measurements, and we used cardiac magnetic resonance imaging to determine left ventricular ejection fraction (LVEF) and cardiac mass. Results: Median age was 65 years and median LVEF was 45%. Median SN concentration was 39 (25th–75th percentile 31–44) pmol/L in the coronary sinus and 37 (30–41) pmol/L in the aortic root (p = 0.02 for difference). SN concentrations in the aortic root showed the highest correlations with N-terminal B-type natriuretic peptide (rho = 0.47) and estimated glomerular filtration rate (rho = −0.41). In contrast, we found weak correlations between SN concentrations and index of myocardial resistance (rho = 0.12), LVEF (rho = 0.08), and cardiac mass (rho = −0.09). Conclusion: We demonstrate a positive trans-cardiac gradient of SN in patients with TTS, which supports the hypothesis that SN is produced and released in the human myocardium in situations of myocardial dysfunction and stress.

1.
Lyngbakken
MN
,
Myhre
PL
,
Røsjø
H
,
Omland
T
.
Novel biomarkers of cardiovascular disease: applications in clinical practice
.
Crit Rev Clin Lab Sci
.
2019
;
56
(
1
):
33
60
.
2.
Røsjø
H
,
Stridsberg
M
,
Florholmen
G
,
Stensløkken
KO
,
Ottesen
AH
,
Sjaastad
I
, et al
.
Secretogranin II; a protein increased in the myocardium and circulation in heart failure with cardioprotective properties
.
PloS One
.
2012
;
7
(
5
):
e37401
.
3.
Ottesen
AH
,
Carlson
CR
,
Eken
OS
,
Sadredini
M
,
Myhre
PL
,
Shen
X
, et al
.
Secretoneurin is an endogenous calcium/calmodulin-dependent protein kinase II inhibitor that attenuates Ca(2+)-dependent arrhythmia
.
Circ Arrhythm Electrophysiol
.
2019
;
12
(
4
):
e007045
.
4.
Ottesen
AH
,
Louch
WE
,
Carlson
CR
,
Landsverk
OJ
,
Kurola
J
,
Johansen
RF
, et al
.
Secretoneurin is a novel prognostic cardiovascular biomarker associated with cardiomyocyte calcium handling
.
J Am Coll Cardiol
.
2015
;
65
(
4
):
339
51
.
5.
Brynildsen
J
,
Myhre
PL
,
Lyngbakken
MN
,
Klaeboe
LG
,
Stridsberg
M
,
Christensen
G
, et al
.
Circulating secretoneurin concentrations in patients with moderate to severe aortic stenosis
.
Clin Biochem
.
2019
;
71
:
17
23
.
6.
Myhre
PL
,
Ottesen
AH
,
Faaren
AL
,
Tveit
SH
,
Springett
J
,
Pyylampi
J
, et al
.
Performance of a novel research-use-only secretoneurin ELISA in patients with suspected acute coronary syndrome: comparison with an established secretoneurin radioimmunoassay
.
Cardiology
.
2021
;
146
(
5
):
566
74
.
7.
Røsjø
H
,
Meessen
J
,
Ottesen
AH
,
Latini
R
,
Omland
T
,
GISSI-HF Investigators
.
Prognostic value of secretoneurin in chronic heart failure. Data from the GISSI-Heart Failure trial
.
Clin Biochem
.
2023
;
118
:
110595
.
8.
Templin
C
,
Ghadri
JR
,
Diekmann
J
,
Napp
LC
,
Bataiosu
DR
,
Jaguszewski
M
, et al
.
Clinical features and outcomes of Takotsubo (stress) cardiomyopathy
.
N Engl J Med
.
2015
;
373
(
10
):
929
38
.
9.
Solberg
OG
,
Aaberge
L
,
Bosse
G
,
Ueland
T
,
Gullestad
L
,
Aukrust
P
, et al
.
Microvascular function and inflammatory activation in Takotsubo cardiomyopathy
.
ESC Heart Fail
.
2023
;
10
(
5
):
3216
22
.
10.
Bybee
KA
,
Kara
T
,
Prasad
A
,
Lerman
A
,
Barsness
GW
,
Wright
RS
, et al
.
Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction
.
Ann Intern Med
.
2004
;
141
(
11
):
858
65
.
11.
Aakre
KM
,
Lyngbakken
MN
,
Faaren
AL
,
Røsjø
H
,
Dalen
H
,
Omland
T
.
Reference intervals of circulating secretoneurin concentrations determined in a large cohortof community dwellers: the HUNT study
.
Clin Chem Lab Med
.
2024
;
0
(
0
).
12.
Levey
AS
,
Stevens
LA
,
Schmid
CH
,
Zhang
YL
,
Castro
AF
3rd
,
Feldman
HI
, et al
.
A new equation to estimate glomerular filtration rate
.
Ann Intern Med
.
2009
;
150
(
9
):
604
12
.
13.
Aakre
KM
,
Ottesen
AH
,
Strand
H
,
Faaren
AL
,
Alaour
B
,
Torsvik
J
, et al
.
Biological variation of secretoneurin; a novel cardiovascular biomarker implicated in arrhythmogenesis
.
Clin Biochem
.
2021
;
98
:
74
7
.
You do not currently have access to this content.